MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
Stock Information for MEI Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.